Stated that they doing a well supported cap raise @ 0.069 that's...

Stated that they doing a well supported cap raise @ 0.069 that's why the SP rise I believe..

Balance sheet strengthened following firm commitments to raise A$5m. Approximately
67.8m shares have been issued to date at an issue price of A$0.069 raising ~A$4.68m
(before costs), with the remainder of the shares subject to shareholder approval.
Placement was strongly supported by a range of local and international investors,
including institutions and sophisticated investors
 Creso Pharma remains well capitalised with A$5,086,000 cash at bank as of 31 March 2022
to progress growth initiatives to leverage the Company’s US expansion (not including
~A$318,000 from the March placement, which remains subject to shareholder approval)